Prot #EFC17757: A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination with Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age with Newl

Project: Research project

Project Details

StatusActive
Effective start/end date4/26/244/26/27

Funding

  • ICON Clinical Research, LLC (Prot #EFC17757 // Prot #EFC17757)
  • Sanofi US Services Inc. (Prot #EFC17757 // Prot #EFC17757)